ARYL AMINOPYRIMIDINES AS DUAL MERTK AND TYRO3 INHIBITORS AND METHODS THEREOF

Aminopyrimidine containing compounds that inhibit both Mer tyrosine kinase (MerTK) activity and Tyro3 kinase activity are disclosed herein. Additionally disclosed are methods of synthesis and use of the aminopyrimidine containing compounds as anti-cancer agents, immunostimulatory and immunomodulator...

Full description

Saved in:
Bibliographic Details
Main Authors Zhou, Yubai, Ding, Ransheng, Frye, Stephen, Wang, Xiaodong, Kong, Deyu
Format Patent
LanguageEnglish
Published 29.12.2022
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Aminopyrimidine containing compounds that inhibit both Mer tyrosine kinase (MerTK) activity and Tyro3 kinase activity are disclosed herein. Additionally disclosed are methods of synthesis and use of the aminopyrimidine containing compounds as anti-cancer agents, immunostimulatory and immunomodulatory agents, anti-platelet agents, anti-infective agents, and as adjunctive agents.
Bibliography:Application Number: US202017755908